Search research articles
Contact Us
Filters
Showing results (571-580 of 594) with videos related to
Page
of 60
Sort By:
Nature Communications
|
October 22, 2016
Genomic heterogeneity of multiple synchronous lung cancer
Yu Liu, Jianjun Zhang, Lin Li, et al.
Journal for Immunotherapy of Cancer
|
October 24, 2024
Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer
Nicolas Zhou, Cheuk H Leung, William N William, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2003
Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy
Stephen G Swisher, Jack A Roth, Ritsuko Komaki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 13, 2023
International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy
Sanja Dacic, William Travis, Mary Redman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 12, 2020
Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC
Lingzhi Hong, Marcelo V Negrao, Seyedeh S Dibaj, et al.
Nature Communications
|
July 7, 2019
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
Xin Hu, Junya Fujimoto, Lisha Ying, et al.
Genome Biology
|
November 5, 2020
Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity
Won-Chul Lee, Alexandre Reuben, Xin Hu, et al.
Nature Communications
|
November 18, 2021
Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer
Ming Chen, Runzhe Chen, Ying Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2021
Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)
Helen X Chen, Minkyung Song, Holden T Maecker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2024
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial
Edwin Roger Parra, Jiexin Zhang, Dzifa Yawa Duose, et al.
Page
of 60
Search research articles
Search
Showing results (571-580 of 594) with videos related to
Sort By:
Page
of 60
Nature Communications
|
October 22, 2016
Genomic heterogeneity of multiple synchronous lung cancer
Yu Liu, Jianjun Zhang, Lin Li, et al.
Journal for Immunotherapy of Cancer
|
October 24, 2024
Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer
Nicolas Zhou, Cheuk H Leung, William N William, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2003
Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy
Stephen G Swisher, Jack A Roth, Ritsuko Komaki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 13, 2023
International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy
Sanja Dacic, William Travis, Mary Redman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 12, 2020
Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC
Lingzhi Hong, Marcelo V Negrao, Seyedeh S Dibaj, et al.
Nature Communications
|
July 7, 2019
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
Xin Hu, Junya Fujimoto, Lisha Ying, et al.
Genome Biology
|
November 5, 2020
Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity
Won-Chul Lee, Alexandre Reuben, Xin Hu, et al.
Nature Communications
|
November 18, 2021
Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer
Ming Chen, Runzhe Chen, Ying Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2021
Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)
Helen X Chen, Minkyung Song, Holden T Maecker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2024
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial
Edwin Roger Parra, Jiexin Zhang, Dzifa Yawa Duose, et al.
Page
of 60